Table 3. The relationship between pre-treatment measurements of ovarian response predictors and outcome (obtaining a cleavage stage embryo) after PRP treatment.
| AFC PRIOR TO PRP | <35 years old (N/Total (%)) | 35-37 years old (N/Total (%)) | 38-40 years old (N/Total (%)) | All ages (N/Total (%)) |
| 0 | 9/73 (12.3%)* | 9/37 (24.3%) | 11/65 (16.9%)* | 29/175 (16.6%)* |
| 1 and 2 | 18/34 (52.9%)* | 10/25 (40.0%) | 20/38 (52.6%)* | 48/97 (49.5%)* |
| AMH PRIOR TO PRP | <35 years old (N/Total (%)) | 35-37 years old (N/Total (%)) | 38-40 years old (N/Total (%)) | All ages (N/Total (%)) |
| <25th percentile (0.01-0.02 ng/mL) | 2/34 (5.9%)† | 4/15 (26.7%) | 9/37 (24.3%) | 15/86 (17.4%)† |
| 25th -100th percentile (0.03-0.82 ng/mL) | 25/73 (34.2%)† | 15/47 (31.9%) | 22/66 (33.3%) | 62/186 (33.3%)† |
| FSH PRIOR TO PRP | <35 years old (N/Total (%)) | 35-37 years old (N/Total (%)) | 38-40 years old (N/Total (%)) | All ages (N/Total (%)) |
| >75thpercentile (44.2-155 mIU/mL) | 1/30 (3.3%)‡ | 2/12 (16.7%) | 2/26 (7.7%)‡ | 5/68 (7.4%)‡ |
| 0th -75th percentile (25-44.1 mIU/mL) | 26/77 (33.8%)‡ | 17/50 (34.0%) | 29/77 (37.7%)‡ | 72/204 (35.3%)‡ |
| TOTAL | 27/107 (25.2%) | 19/62 (30.6%) | 31/103 (30.1%) | 77/272 (28.3%) |
Table shows the number of women who had at least one mature oocyte retrieved per women treated in each age group. Data shown as grouped according to pre-treatment AFC, AMH OR FSH. All women who participated in the study were included (n=311), except those who conceived spontaneously (n=23) and those who did not have all parameters recorded (n=16). *: p<0.05 in the age group according to pre-treatment AFC (0 vs 1 or 2); †: p<0.05 in the age group according to pre-treatment AMH (<25th percentile vs 25th-100th percentile); ‡: p<0.05 in the age group according to pre-treatment FSH (>75th percentile vs 0th-75th percentile).